(Q38448312)

3 September 2017

1 reference

title

Lactobacillus species: taxonomic complexity and controversial susceptibilities (English)

1 reference

3 September 2017

author

Ellie J. C. Goldstein

series ordinal

1

object named as

Ellie J C Goldstein

1 reference

3 September 2017

2

Kerin L Tyrrell

1 reference

3 September 2017

3

Diane M Citron

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

Clinical Infectious Diseases

3 September 2017

published in

1 reference

3 September 2017

volume

60 Suppl 2

1 reference

3 September 2017

page(s)

S98-107

1 reference

Lactic acid bacteria and human clinical infection

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Quantification of bacterial species of the vaginal microbiome in different groups of women, using nucleic acid amplification tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Bacteriocin production by strain Lactobacillus delbrueckii ssp. bulgaricus BB18 during continuous prefermentation of yogurt starter culture and subsequent batch coagulation of milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus rhamnosus bacteremia: an emerging clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus fermentum, a pathogen in documented cholecystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Acute acalculous cholecystitis complicated with peritonitis caused by Lactobacillus plantarum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

A retrospective review of cases of anaerobic empyema and update of bacteriology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Endocarditis caused by Lactobacillus jensenii in an immunocompetent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus paracasei endocarditis in a consumer of probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus rhamnosus Meningitis following Recurrent Episodes of Bacteremia in a Child Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus paracasei continuous ambulatory peritoneal dialysis-related peritonitis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Isolated Lactobacillus chronic prosthetic knee infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Investigation of inpatient probiotic use at an academic medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Antibiotic resistance in probiotic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Antimicrobial activity of MDL 63,246, a new semisynthetic glycopeptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Acquired macrolide resistance in the human intestinal strain Lactobacillus rhamnosus E41 associated with a transition mutation in 23S rRNA genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Characterization and transfer of antibiotic resistance in lactic acid bacteria from fermented food products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobac

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Comparative In vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

Comparison of the CLSI guideline and ISO/IDF standard for antimicrobial susceptibility testing of Lactobacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV072

21 January 2018

Identifiers

DOI

10.1093/CID/CIV072

1 reference

3 September 2017

1 reference